Drug Discovery Today Reviews
YCMD has conducted a comprehensive meta-analysis of FDA approved drugs published in a series of Drug Discovery Today manuscripts. Click on a title below for access to the story.
An analysis of original research contributions toward FDA-approved drugs.
A history of drug development in four acts.
Target selection for FDA-approved medicines
Post-approval fate of pharmaceutical companies
An overview of FDA-approved biologics medicines
An analysis of FDA-approved drugs for oncology
Trends in pharmaceutical targeting of clinical indications: 1930-2013
The rise (and decline?) of biotechnology
An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs
An analysis of FDA-approved drugs for pain and anesthesia
An analysis of FDA-approved drugs for cardiovascular diseases
An analysis of FDA-approved drugs for psychiatric disorders
An analysis of FDA-approved drugs for infectious disease: antibacterial agents
An overview of FDA-approved new molecular entities: 1827-2013
An analysis of FDA-approved drugs: natural products and their derivatives
An analysis of FDA-approved drugs for metabolic diseases
An analysis of FDA-approved drugs for neurological disorders